Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Merck
AstraZeneca
Harvard Business School
Moodys
Express Scripts
Colorcon

Last Updated: May 27, 2022

CLINICAL TRIALS PROFILE FOR ACARBOSE


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Acarbose

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000620 ↗ Action to Control Cardiovascular Risk in Diabetes (ACCORD) Completed Centers for Disease Control and Prevention Phase 3 1999-09-01 The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 ↗ Action to Control Cardiovascular Risk in Diabetes (ACCORD) Completed National Eye Institute (NEI) Phase 3 1999-09-01 The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
NCT00000620 ↗ Action to Control Cardiovascular Risk in Diabetes (ACCORD) Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Phase 3 1999-09-01 The purpose of this study is to prevent major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes mellitus using intensive glycemic control, intensive blood pressure control, and multiple lipid management.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Acarbose

Condition Name

Condition Name for Acarbose
Intervention Trials
Type 2 Diabetes Mellitus 23
Diabetes Mellitus, Type 2 14
Diabetes Mellitus 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Acarbose
Intervention Trials
Diabetes Mellitus 57
Diabetes Mellitus, Type 2 51
Glucose Intolerance 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Acarbose

Trials by Country

Trials by Country for Acarbose
Location Trials
China 93
United States 42
Canada 9
Korea, Republic of 8
Spain 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Acarbose
Location Trials
Washington 5
New York 3
Minnesota 3
Texas 3
Tennessee 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Acarbose

Clinical Trial Phase

Clinical Trial Phase for Acarbose
Clinical Trial Phase Trials
Phase 4 36
Phase 3 18
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Acarbose
Clinical Trial Phase Trials
Completed 55
Unknown status 18
Terminated 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Acarbose

Sponsor Name

Sponsor Name for Acarbose
Sponsor Trials
Bayer 13
Sanofi 4
Canadian Institutes of Health Research (CIHR) 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Acarbose
Sponsor Trials
Other 85
Industry 42
NIH 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
AstraZeneca
McKesson
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.